A Dose Escalation Study of Cabozantinib Administered Alone or in Combination with Atezolizumab in Subjects with Locally Advanced or Metastatic Solid Tumors (XL184-021)
A Dose Escalation Study of Cabozantinib Administered Alone or in Combination with Atezolizumab in Subjects with Locally Advanced or Metastatic Solid Tumors (XL184-021)
Trial Category:
Other Solid Tumor
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
